| CAS No.: | 2381089-83-2 |
|---|---|
| Formula: | C50h69n15o9 |
| EINECS: | 1308068-626-2 |
| Type: | Pharmaceutical Intermediates |
| Appearance: | Powder |
| Quality: | Technical |
| Samples: |
|---|
| Customization: |
|---|
Suppliers with verified business licenses
Audited Supplier 
Retatrutide is a triple glucagon, GIP, and GLP-1 receptor agonist. Retatrutide showed glucose control
and weight loss in patients with type 2 diabetes mellitus (T2DM).
What Is Retatrutide?
Retatrutide (LY-3437943) is under development for the treatment of type 2 diabetes mellitus, obstructive sleep
apnea, osteoarthritis, obesity and non-alcoholic fatty liver disease. The drug candidate is administered through
subcutaneous and intravenous route. The drug candidate acts by targeting glucagon-like peptide 1 (GLP-1),
glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors. It is a new molecular entity.
Retatrutide: Are There Any Side Effects?
Although no serious side effects were reported during phase 2 trials, Retatrutide is suspected to give rise to
some common side effects experienced when GLP-1 receptors including constipation, nausea, vomiting,
and diarrhea. In phase 2 clinical trials, researchers also saw a surge in heart rate in adults administered with
a higher Retatrutide dose after 6 months, but the symptoms declined accordingly.
However, side effects can be avoided by using a lower starting dose of Retatrutide.
As of now, Retatrutide is set up for phase 3 clinical trials, and the trials with the participation of thousands of
individuals diagnosed with obesity and other weight-related illnesses won't finish until 2025. During the trials,
researchers will investigate its safety and possible side effects when used for a long time.
While the possibility of Retatrutide's approval to the public is unpredictable, at least by 2026 or 2027, it is
essential to exercise caution when implementing pharmaceutical interventions to lose weight. No weight loss
drug guarantees substantial weight loss unless you adopt healthy lifestyle choices, such as exercising, eating
nutrient-dense, balanced diets, cutting back on sugary and processed foods and beverages, etc.
You Get What You Paid For :
| 2mg | 5mg | 10mg | |
| Semaglutide | $80/Box | $130/Box | $230/Box |
| Tirzepatide | $90/Box | $150/Box | $260/Box |
| Retatrutide | $150/Box | $290/Box | $520/Box |
It's in US Dollar, 10vials per Box. Price is negotiated if order in bulk. Good quality with after-sale
service superior to peers.
For Research Purpose Only.
Purchasing objects are required to be companies and labs, not for personal use.
Suppliers with verified business licenses
Audited Supplier 
){kind=link}
){kind=link}